Neurofibromatosis type 1: new insights into neurocognitive issues.
about
Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competenceActivated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated ProteinsAstrocytes: biology and pathologyTherapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosisA distinct set of Drosophila brain neurons required for neurofibromatosis type 1-dependent learning and memory.Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1.Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena/VASP pathway.Modeling cognitive dysfunction in neurofibromatosis-1mTOR, a Potential Target to Treat Autism Spectrum Disorder.Conflict processing in juvenile patients with neurofibromatosis type 1 (NF1) and healthy controls - Two pathways to success.Application of the International Classification of Functioning, Disability and Health in children with neurofibromatosis type 1: a review.Inhibition and termination of physiological responses by GTPase activating proteins.New models for considering the role of medication in the treatment and elucidation of the etiology of autism.Numerical activities of daily living in adults with neurofibromatosis type 1.Glial cells as key elements in the pathophysiology and treatment of bipolar disorder.Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attentionAttention skills in children with neurofibromatosis type 1.Computerized cognitive training for children with neurofibromatosis type 1: A pilot resting-state fMRI study.Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.Is there a relationship between executive functions and academic success in children with neurofibromatosis type 1?Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT.Translational medicine: Mice and men show the way.Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.RASopathies are associated with a distinct personality profile.The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.Executive Function Deficits in Seriously Ill Children-Emerging Challenges and Possibilities for Clinical Care.Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se
P2860
Q26862596-E8E3E408-A82E-4484-8D0F-45701A0ABC11Q27027458-6BF76623-1553-473D-9F4B-4128319FBF60Q27490746-846E7766-D8E4-47F0-8A2F-39F43AB201D4Q30357776-DB55A18F-DCD5-4A38-8A97-96AFB9478ABFQ34051144-774A06AF-4947-4D57-9C2D-B83664C4E2EEQ34481152-8A840ADD-8313-4A2A-8660-5E73427F4788Q35998035-B9A51590-4AD1-40EE-AF45-446D14AAF062Q36118445-F8AF2875-3B66-42FD-BB02-2D3FC47C3AF1Q36756183-8789FE40-8D0C-4021-908F-73473A762C7AQ37350523-C8E1AD94-EA16-4479-A714-CEF5DD94B822Q37682749-C3BFAE92-38DA-47D1-8C25-24FBA4D5445EQ37699438-634D8AC2-F2AE-41E3-A7ED-49259ECF8967Q37980724-A60C4B9D-FBBD-408A-8CA3-C65722114254Q38044266-18687838-C092-474C-B7E9-68DF08D0BF63Q38602516-E4FC8DA2-871C-4B30-9344-4B11EDCE64F6Q38738216-151E6A7D-AA44-4300-A7D4-F20B546F28C8Q38831064-C6FCCA4B-15AC-4DB5-8AF4-1E852CCFA9D9Q46042711-B65C6508-BE83-478C-B02D-325A5F7C284BQ46056122-0F9A8E44-AF4D-49EF-A514-F43DBEB7CF0FQ47150280-E0DC730A-CC8E-400A-B855-156A46BAEF14Q47765442-0EBC177A-D173-41D5-AA23-1B510A2D20B4Q48302882-91F904F4-2570-4533-8DBD-49336D6A17FAQ50100657-009FCAD4-897A-490B-96B0-D3E65A86D071Q50304062-D51166FC-B662-4235-8D8A-B97ECF9B023CQ50655894-7E27BDCB-74B1-4473-845D-10B14C653A9CQ52320476-4285F3B1-9BAA-4DB9-B56D-21DFDDC42D27Q53126759-A745C97D-CD57-4E1C-8D18-76C6C746B455Q55028716-3ECF821B-EFF8-4B9E-8E1C-FB3593CFD34EQ57581441-C916E5DA-C6AE-41DA-AFCA-0247B6C3209D
P2860
Neurofibromatosis type 1: new insights into neurocognitive issues.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Neurofibromatosis type 1: new insights into neurocognitive issues.
@ast
Neurofibromatosis type 1: new insights into neurocognitive issues.
@en
type
label
Neurofibromatosis type 1: new insights into neurocognitive issues.
@ast
Neurofibromatosis type 1: new insights into neurocognitive issues.
@en
prefLabel
Neurofibromatosis type 1: new insights into neurocognitive issues.
@ast
Neurofibromatosis type 1: new insights into neurocognitive issues.
@en
P2860
P1476
Neurofibromatosis type 1: new insights into neurocognitive issues.
@en
P2093
Gerard A Gioia
Maria T Acosta
P2860
P2888
P304
P356
10.1007/S11910-996-0036-5
P577
2006-03-01T00:00:00Z